BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Półtorak-Szymczak G, Budlewski T, Furmanek MI, Wierzba W, Sklinda K, Walecki J, Mruk B. Radiological Imaging of Gastro-Entero-Pancreatic Neuroendocrine Tumors. The Review of Current Literature Emphasizing the Diagnostic Value of Chosen Imaging Methods. Front Oncol 2021;11:670233. [PMID: 34211845 DOI: 10.3389/fonc.2021.670233] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Chiapponi C, Bruns CJ. Moderne molekulare und bildgebende Diagnostik bei neuroendokrinen Neoplasien des Pankreas. best practice onkologie 2022. [DOI: 10.1007/s11654-022-00451-y] [Reference Citation Analysis]
2 Chiapponi C, Bruns CJ. Moderne molekulare und bildgebende Diagnostik bei neuroendokrinen Neoplasien des Pankreas. Chirurgie 2022;93:731-738. [DOI: 10.1007/s00104-022-01645-4] [Reference Citation Analysis]
3 Ilhan H, Schnitzer ML, Rübenthaler J. Neuroendokrine Tumoren – von der morphologischen zur funktionellen Bildgebung. Radiopraxis 2022;15:E35-E47. [DOI: 10.1055/a-1714-2040] [Reference Citation Analysis]
4 Canakis A, Lee LS. Current updates and future directions in diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms. World J Gastrointest Endosc 2022; 14(5): 267-290 [DOI: 10.4253/wjge.v14.i5.267] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Kaliszewski K, Ludwig M, Greniuk M, Mikuła A, Zagórski K, Rudnicki J. Advances in the Diagnosis and Therapeutic Management of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs). Cancers (Basel) 2022;14:2028. [PMID: 35454934 DOI: 10.3390/cancers14082028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Ilhan H, Schnitzer M, Rübenthaler J. Neuroendokrine Tumoren – von der morphologischen zur funktionellen Bildgebung. Onkologie up2date 2022;04:93-106. [DOI: 10.1055/a-1712-0674] [Reference Citation Analysis]
7 Kaewput C, Vinjamuri S. Role of Combined 68Ga DOTA-Peptides and 18F FDG PET/CT in the Evaluation of Gastroenteropancreatic Neuroendocrine Neoplasms. Diagnostics 2022;12:280. [DOI: 10.3390/diagnostics12020280] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Ilhan H, Schnitzer ML, Rübenthaler J. Neuroendokrine Tumoren – von der morphologischen zur funktionellen Bildgebung. Der Nuklearmediziner 2021;44:313-325. [DOI: 10.1055/a-1652-4899] [Reference Citation Analysis]
9 Granata V, Coppola F, Grassi R, Fusco R, Tafuto S, Izzo F, Reginelli A, Maggialetti N, Buccicardi D, Frittoli B, Rengo M, Bortolotto C, Prost R, Lacasella GV, Montella M, Ciaghi E, Bellifemine F, De Muzio F, Danti G, Grazzini G, De Filippo M, Cappabianca S, Barresi C, Iafrate F, Stoppino LP, Laghi A, Grassi R, Brunese L, Neri E, Miele V, Faggioni L. Structured Reporting of Computed Tomography in the Staging of Neuroendocrine Neoplasms: A Delphi Consensus Proposal. Front Endocrinol 2021;12:748944. [DOI: 10.3389/fendo.2021.748944] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]